ATE543796T1 - 24-sulfoximine vitamin d3 derivate - Google Patents
24-sulfoximine vitamin d3 derivateInfo
- Publication number
- ATE543796T1 ATE543796T1 AT03727105T AT03727105T ATE543796T1 AT E543796 T1 ATE543796 T1 AT E543796T1 AT 03727105 T AT03727105 T AT 03727105T AT 03727105 T AT03727105 T AT 03727105T AT E543796 T1 ATE543796 T1 AT E543796T1
- Authority
- AT
- Austria
- Prior art keywords
- compounds
- derivatives
- sulfoximine
- vitamin
- sulfoximine vitamin
- Prior art date
Links
- 150000003704 vitamin D3 derivatives Chemical class 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- GMRQFYUYWCNGIN-UHFFFAOYSA-N 1,25-Dihydroxy-vitamin D3' Natural products C1CCC2(C)C(C(CCCC(C)(C)O)C)CCC2C1=CC=C1CC(O)CC(O)C1=C GMRQFYUYWCNGIN-UHFFFAOYSA-N 0.000 abstract 1
- 102100027518 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial Human genes 0.000 abstract 1
- 101000861278 Homo sapiens 1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial Proteins 0.000 abstract 1
- 235000020964 calcitriol Nutrition 0.000 abstract 1
- 239000011612 calcitriol Substances 0.000 abstract 1
- GMRQFYUYWCNGIN-NKMMMXOESA-N calcitriol Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@@H](CCCC(C)(C)O)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C GMRQFYUYWCNGIN-NKMMMXOESA-N 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000005555 sulfoximide group Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Diabetes (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US38790402P | 2002-06-13 | 2002-06-13 | |
| PCT/CA2003/000851 WO2003106411A1 (en) | 2002-06-13 | 2003-06-13 | 24-sulfoximine vitamin d3 compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE543796T1 true ATE543796T1 (de) | 2012-02-15 |
Family
ID=29736378
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03727105T ATE543796T1 (de) | 2002-06-13 | 2003-06-13 | 24-sulfoximine vitamin d3 derivate |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US7101865B2 (de) |
| EP (1) | EP1511725B1 (de) |
| JP (1) | JP4490262B2 (de) |
| AT (1) | ATE543796T1 (de) |
| AU (1) | AU2003233735A1 (de) |
| CA (1) | CA2488334C (de) |
| ES (1) | ES2380748T3 (de) |
| WO (1) | WO2003106411A1 (de) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2006032299A1 (en) * | 2004-09-24 | 2006-03-30 | Susanna Miettinen | Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| WO2006036892A2 (en) * | 2004-09-24 | 2006-04-06 | Sapphire Therapeutics, Inc. | Use of inhibitors of 24-hydroxylase in the treatment of cancer |
| US20070122477A1 (en) * | 2005-10-12 | 2007-05-31 | Cytochroma, Inc. | Methods and articles for treating 25-hydroxyvitamin D insufficiency and deficiency |
| CA2882048C (en) | 2006-02-03 | 2020-03-24 | Opko Renal, Llc | Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3 |
| HUE037309T2 (hu) | 2006-06-21 | 2018-08-28 | Opko Ireland Global Holdings Ltd | Terápia D-vitamin telítési szer alkalmazásával és D-vitamin hormon helyettesítõ szer |
| ES2401205T3 (es) * | 2007-04-25 | 2013-04-17 | Cytochroma Inc. | Composiciones de orales de liberación controlada que comprende un compuesto de vitamina D y un soporte céreo |
| WO2009047644A2 (en) * | 2007-04-25 | 2009-04-16 | Cytochroma Inc. | Method of treating vitamin d insufficiency and deficiency |
| CA2684778C (en) * | 2007-04-25 | 2017-09-05 | Cytochroma Inc. | Methods and compounds for vitamin d therapy |
| CA2683514C (en) | 2007-04-25 | 2019-07-09 | Proventiv Therapeutics, Llc | Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease |
| KR101685031B1 (ko) | 2008-04-02 | 2016-12-09 | 사이토크로마 인코포레이티드 | 비타민 ｄ 결핍 및 관련 장애에 유용한 방법, 조성물, 용도 및 키트 |
| WO2011088209A2 (en) * | 2010-01-13 | 2011-07-21 | Cytochroma Inc. | 1-deoxy analogs of vitamin d-related compounds |
| CN103037902A (zh) | 2010-03-29 | 2013-04-10 | 赛特克罗公司 | 用于降低甲状旁腺水平的方法和组合物 |
| US8754067B2 (en) | 2010-11-12 | 2014-06-17 | Wisconsin Alumni Research Foundation | 22-haloacetoxy-homopregnacalciferol analogs and their uses |
| KR101847947B1 (ko) | 2013-03-15 | 2018-05-28 | 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 | 안정화되고 변형된 비타민 ｄ 방출 제형 |
| US10220047B2 (en) | 2014-08-07 | 2019-03-05 | Opko Ireland Global Holdings, Ltd. | Adjunctive therapy with 25-hydroxyvitamin D and articles therefor |
| EP4596045A3 (de) | 2016-03-28 | 2025-10-15 | EirGen Pharma Ltd. | Verfahren zur behandlung von vitamin d |
| CN110396114B (zh) * | 2019-08-07 | 2021-08-27 | 成都理工大学 | 一种n-二芳基氧膦基亚砜亚胺的合成方法 |
| WO2025094144A1 (en) | 2023-11-02 | 2025-05-08 | Eirgen Pharma Ltd. | Controlling loss of kidney function |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4481198A (en) | 1984-02-13 | 1984-11-06 | Wisconsin Alumni Research Foundation | Vitamin D metabolism inhibitor |
| US4973584A (en) | 1989-03-09 | 1990-11-27 | Deluca Hector F | Novel 1α-hydroxyvitamin D2 epimer and derivatives |
| DE3908937A1 (de) | 1989-03-18 | 1990-09-20 | Hauni Werke Koerber & Co Kg | Verfahren zum herstellen von schnittabak |
| GB9007236D0 (en) | 1990-03-30 | 1990-05-30 | Leo Pharm Prod Ltd | Chemical compounds |
| JP2900607B2 (ja) * | 1992-02-28 | 1999-06-02 | 三菱自動車工業株式会社 | 吸排気可変機構付きエンジンの制御装置 |
| GB9223061D0 (en) | 1992-11-04 | 1992-12-16 | Leo Pharm Prod Ltd | Chemical compounds |
| GB9226877D0 (en) | 1992-12-23 | 1993-02-17 | Leo Pharm Prod Ltd | Chemical compounds |
| JP3759639B2 (ja) * | 1994-04-11 | 2006-03-29 | 中外製薬株式会社 | ２２−チアビタミン▲ｄ３▼誘導体 |
| JP4012293B2 (ja) * | 1996-12-20 | 2007-11-21 | 中外製薬株式会社 | １６−エン−ビタミンｄ誘導体 |
| US6043386A (en) | 1998-06-03 | 2000-03-28 | John Hopkins University | Non-calcemic, antiproliferative, transcriptionally active 24-fluorinated hybrid analogs of 1α,-25-dihydroxy vitamin D3 |
| WO2000059513A1 (en) | 1999-04-01 | 2000-10-12 | Johns Hopkins University | NON-CALCEMIC, ANTIPROLIFERATIVE, TRANSCRIPTIONALLY ACTIVE SULFUR-CONTAINING ANALOGS OF 1α, 25-DIHYDROXY VITAMIN D¿3? |
| AU2001248777A1 (en) * | 2000-04-19 | 2001-10-30 | Chugai Seiyaku Kabushiki Kaisha | Vitamin d derivatives |
| US7288407B2 (en) | 2002-05-02 | 2007-10-30 | Cytochroma, Inc. | Stable cytochrome P450 24 (CYP24) expressing cell line and methods and uses thereof |
-
2003
- 2003-06-13 WO PCT/CA2003/000851 patent/WO2003106411A1/en not_active Ceased
- 2003-06-13 ES ES03727105T patent/ES2380748T3/es not_active Expired - Lifetime
- 2003-06-13 JP JP2004513244A patent/JP4490262B2/ja not_active Expired - Fee Related
- 2003-06-13 CA CA2488334A patent/CA2488334C/en not_active Expired - Fee Related
- 2003-06-13 EP EP03727105A patent/EP1511725B1/de not_active Expired - Lifetime
- 2003-06-13 AT AT03727105T patent/ATE543796T1/de active
- 2003-06-13 US US10/460,656 patent/US7101865B2/en not_active Expired - Lifetime
- 2003-06-13 AU AU2003233735A patent/AU2003233735A1/en not_active Abandoned
-
2006
- 2006-05-30 US US11/442,148 patent/US7973024B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| US20060217353A1 (en) | 2006-09-28 |
| AU2003233735A8 (en) | 2003-12-31 |
| US7973024B2 (en) | 2011-07-05 |
| EP1511725B1 (de) | 2012-02-01 |
| ES2380748T3 (es) | 2012-05-18 |
| CA2488334A1 (en) | 2003-12-24 |
| US7101865B2 (en) | 2006-09-05 |
| JP2005529183A (ja) | 2005-09-29 |
| CA2488334C (en) | 2010-12-07 |
| JP4490262B2 (ja) | 2010-06-23 |
| EP1511725A1 (de) | 2005-03-09 |
| WO2003106411A1 (en) | 2003-12-24 |
| US20040038949A1 (en) | 2004-02-26 |
| AU2003233735A1 (en) | 2003-12-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1106638T1 (el) | Χαμηλα - υπερασβεστεμικα οξιμης αναλογα της 1αλφα, 25-διϋδροξυ βιταμινη d3 | |
| AU2003233735A8 (en) | 24-sulfoximine vitamin d3 compounds | |
| MX2009011211A (es) | Indoles sustituidos en la posicion 7 inhibidores de mci-1. | |
| CY1110555T1 (el) | 4-((φαινοξυαλκυλ)θειο)-φαινοξυοξεικα οξεα και αναλογα | |
| DK1625126T3 (da) | Imidazo- og thiazolopyridiner som JAK3-kinaseinhibitorer | |
| MX2009011210A (es) | Inhibidores de mcl1 de indol 7-no sustituido. | |
| NO20061845L (no) | Fenyl-piperazinderivater som modulatorer for muskarine reseptorer | |
| NO20081421L (no) | Midler for hindring og behandling av forstyrrelser som involverer modulering av RYR-reseptorer | |
| EA200900828A1 (ru) | Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1 | |
| NO20045589L (no) | Nye forbindelser | |
| CY1109104T1 (el) | 1,2,3,4 τετρα-υποκατεστημενη ινδολη για την αντιμετωπιση ασθενειων του αναπνευστικου | |
| MY137040A (en) | Fluoro substituted cycloalkanoindoles, compositions containing such compounds and methods of treatment | |
| NO20071078L (no) | Antivirale forbindelser | |
| NO20070866L (no) | Antivirale forbindelser. | |
| NO20053972L (no) | Aminosyre-avledede prodrug av propofol, sammensetninger og anvendelse derav. | |
| SV2009003212A (es) | Inhibidores de metaloproteasa derivados de heterociclicos ref. prd2727svpct | |
| WO2005028678A3 (en) | Methods and materials for identifying agents which modulate bone remodeling and agents identified thereby | |
| BR112022003584A2 (pt) | Compostos de pirrolopirimidina inibidores de perk | |
| MY141528A (en) | Anilinopyrazole derivatives useful for the treatment of diabetes | |
| EA201000675A1 (ru) | Производные хромана как модуляторы trpv3 | |
| NO20073369L (no) | Modulatorer av muskarinreseptorer | |
| ATE443044T1 (de) | Tace inhibitoren | |
| WO2004054968A3 (en) | 25-so2-substituted analogs of 1alpha, 25-dihydroxyvitamin d3 (calcitriol) | |
| EP1539727A4 (de) | Verbindungen, zusammensetzungen und verfahren | |
| DK1441724T3 (da) | Fremgangsmåde til forögelse af endogene testosteronniveauer |